Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction

NCT: NCT07546968 · COMPLETED

NCT IDNCT07546968
StatusCOMPLETED
Start Date2012-09-06
Completion2025-12-31

Brief Summary

Background: Closed-incision negative pressure wound therapy (ciNPWT) is effective in reducing postoperative complications, yet its use in free flap breast reconstruction mastectomy wound remains controversial due to concerns that external pressure may compromise the microvascular pedicle. Methods: A retrospective comparative study was conducted on 253 patients (283 flaps) undergoing immediate DIEP flap reconstruction between 2012 and 2025. Patients were stratified into a ciNPWT group and a conventional dressing group. Outcomes included flap survival, wound complications, healing time, and length of stay (LOS). Multivariable regression models adjusted for confounders, including BMI and neoadjuvant chemotherapy.

Frequently Asked Questions

What is CiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction?

CiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction is a clinical trial registered under NCT07546968. Current status: COMPLETED.

What is the status of NCT07546968?

The current status of NCT07546968 (CiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction) is: COMPLETED.

When did CiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction start?

CiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction started on 2012-09-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.